Todd Harris, Head of Corporate Development at Sienna Biopharmaceuticals, Inc. (SNNA), sold 975 shares at $20.00 ($20K) on 2018-04-25, disclosed to the SEC on 2018-04-25.
Scheduled sale ($20k) by Head of Corporate Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 525 | $11K | 53.8% |
| 2 | $20.00 | 150 | $3K | 15.4% |
| 3 | $20.00 | 300 | $6K | 30.8% |
| Total | $20.00 avg | 975 | $20K | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |